UM

Browse/Search Results:  1-3 of 3 Help

Filters                    
Selected(0)Clear Items/Page:    Sort:
Sustained delivery by a cyclodextrin material-based nanocarrier potentiates antiatherosclerotic activity of rapamycin via selectively inhibiting mTORC1 in mice Journal article
Journal of Controlled Release, 2016,Volume: 235,Page: 48-62
Authors:  Dou Y.;  Guo J.;  Chen Y.;  Han S.;  Xu X.;  Shi Q.;  Jia Y.;  Liu Y.;  Deng Y.;  Wang R.;  Li X.;  Zhang J.
Favorite  |  View/Download:4/0  |  Submit date:2018/11/06
Atherosclerosis  Cyclodextrin  Mtor  Nanomedicine  Rapamycin  Sustained Delivery  
Nanomaterial-dependent immunoregulation of dendritic cells and its effects on biological activities of contraceptive nanovaccines Journal article
Journal of Controlled Release, 2016,Volume: 225,Page: 252-258
Authors:  Xu P.;  Tang S.;  Jiang L.;  Yang L.;  Zhang D.;  Feng S.;  Zhao T.;  Dong Y.;  He W.;  Wang R.;  Zhang J.;  Liang Z.
Favorite  |  View/Download:4/0  |  Submit date:2018/11/06
Cyclodextrin  Dendritic Cell  Intracellular Delivery  Nanoparticle  Peptide Antigen  Ph-responsive  
Nanoparticle-mediated inhibition of survivin to overcome drug resistance in cancer therapy Journal article
Journal of Controlled Release, 2016,Volume: 240,Page: 454
Authors:  Wang S.;  Xu Y.;  Chan H.F.;  Kim H.-W.;  Wang Y.;  Leong K.W.;  Chen M.
Favorite  |  View/Download:4/0  |  Submit date:2018/10/31
Apoptosis  Cancer  Drug Resistance  Nanoparticles  Survivin